nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—ALB—multiple sclerosis	0.616	1	CbGaD
Auranofin—ALB—Prednisone—multiple sclerosis	0.0126	0.666	CbGbCtD
Auranofin—ALB—Methotrexate—multiple sclerosis	0.0063	0.334	CbGbCtD
Auranofin—PRDX5—brainstem—multiple sclerosis	0.00604	0.162	CbGeAlD
Auranofin—PRDX5—medulla oblongata—multiple sclerosis	0.00421	0.113	CbGeAlD
Auranofin—Hepatic enzyme increased—Fingolimod—multiple sclerosis	0.00398	0.0329	CcSEcCtD
Auranofin—PRDX5—midbrain—multiple sclerosis	0.00385	0.104	CbGeAlD
Auranofin—PRDX5—spinal cord—multiple sclerosis	0.00376	0.101	CbGeAlD
Auranofin—Interstitial pneumonia—Azathioprine—multiple sclerosis	0.00359	0.0297	CcSEcCtD
Auranofin—PRDX5—nervous system—multiple sclerosis	0.00316	0.0851	CbGeAlD
Auranofin—PRDX5—central nervous system—multiple sclerosis	0.00305	0.082	CbGeAlD
Auranofin—Interstitial lung disease—Cladribine—multiple sclerosis	0.00301	0.0249	CcSEcCtD
Auranofin—PRDX5—cerebellum—multiple sclerosis	0.00298	0.0801	CbGeAlD
Auranofin—Interstitial pneumonia—Mitoxantrone—multiple sclerosis	0.0029	0.024	CcSEcCtD
Auranofin—Interstitial lung disease—Azathioprine—multiple sclerosis	0.00245	0.0203	CcSEcCtD
Auranofin—PRDX5—brain—multiple sclerosis	0.00242	0.0651	CbGeAlD
Auranofin—Weight decreased—Fingolimod—multiple sclerosis	0.00214	0.0177	CcSEcCtD
Auranofin—Aplastic anaemia—Cladribine—multiple sclerosis	0.002	0.0166	CcSEcCtD
Auranofin—Interstitial lung disease—Mitoxantrone—multiple sclerosis	0.00198	0.0164	CcSEcCtD
Auranofin—IKBKB—nervous system—multiple sclerosis	0.00187	0.0504	CbGeAlD
Auranofin—IKBKB—central nervous system—multiple sclerosis	0.0018	0.0485	CbGeAlD
Auranofin—Eye disorder—Fingolimod—multiple sclerosis	0.00177	0.0146	CcSEcCtD
Auranofin—IKBKB—cerebellum—multiple sclerosis	0.00176	0.0474	CbGeAlD
Auranofin—Alopecia—Fingolimod—multiple sclerosis	0.00167	0.0138	CcSEcCtD
Auranofin—Aplastic anaemia—Azathioprine—multiple sclerosis	0.00163	0.0135	CcSEcCtD
Auranofin—Proteinuria—Mitoxantrone—multiple sclerosis	0.0016	0.0132	CcSEcCtD
Auranofin—Protein urine present—Mitoxantrone—multiple sclerosis	0.00157	0.013	CcSEcCtD
Auranofin—Hepatic enzyme increased—Mitoxantrone—multiple sclerosis	0.00148	0.0123	CcSEcCtD
Auranofin—Leukopenia—Fingolimod—multiple sclerosis	0.00147	0.0122	CcSEcCtD
Auranofin—Interstitial pneumonia—Methotrexate—multiple sclerosis	0.00145	0.012	CcSEcCtD
Auranofin—IKBKB—brain—multiple sclerosis	0.00143	0.0385	CbGeAlD
Auranofin—Eosinophilia—Cladribine—multiple sclerosis	0.00133	0.011	CcSEcCtD
Auranofin—Pancytopenia—Cladribine—multiple sclerosis	0.00127	0.0105	CcSEcCtD
Auranofin—Neutropenia—Cladribine—multiple sclerosis	0.00125	0.0104	CcSEcCtD
Auranofin—Conjunctivitis—Cladribine—multiple sclerosis	0.00116	0.0096	CcSEcCtD
Auranofin—Pancytopenia—Azathioprine—multiple sclerosis	0.00103	0.00855	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Mitoxantrone—multiple sclerosis	0.00102	0.00842	CcSEcCtD
Auranofin—Eye disorder—Cladribine—multiple sclerosis	0.001	0.00828	CcSEcCtD
Auranofin—Interstitial lung disease—Methotrexate—multiple sclerosis	0.000987	0.00817	CcSEcCtD
Auranofin—Pruritus—Fingolimod—multiple sclerosis	0.00095	0.00786	CcSEcCtD
Auranofin—Alopecia—Cladribine—multiple sclerosis	0.000947	0.00783	CcSEcCtD
Auranofin—Flatulence—Cladribine—multiple sclerosis	0.000919	0.0076	CcSEcCtD
Auranofin—Diarrhoea—Fingolimod—multiple sclerosis	0.000919	0.0076	CcSEcCtD
Auranofin—Agranulocytosis—Azathioprine—multiple sclerosis	0.000906	0.00749	CcSEcCtD
Auranofin—Gingivitis—Methotrexate—multiple sclerosis	0.00089	0.00736	CcSEcCtD
Auranofin—Anaemia—Cladribine—multiple sclerosis	0.000862	0.00713	CcSEcCtD
Auranofin—ALB—brain—multiple sclerosis	0.000836	0.0225	CbGeAlD
Auranofin—Pancytopenia—Mitoxantrone—multiple sclerosis	0.000836	0.00691	CcSEcCtD
Auranofin—Neutropenia—Mitoxantrone—multiple sclerosis	0.000823	0.00681	CcSEcCtD
Auranofin—Weight decreased—Mitoxantrone—multiple sclerosis	0.000796	0.00659	CcSEcCtD
Auranofin—Proteinuria—Methotrexate—multiple sclerosis	0.000795	0.00658	CcSEcCtD
Auranofin—Protein urine present—Methotrexate—multiple sclerosis	0.000784	0.00649	CcSEcCtD
Auranofin—Alopecia—Azathioprine—multiple sclerosis	0.00077	0.00637	CcSEcCtD
Auranofin—Jaundice—Mitoxantrone—multiple sclerosis	0.000765	0.00633	CcSEcCtD
Auranofin—Stomatitis—Mitoxantrone—multiple sclerosis	0.000765	0.00633	CcSEcCtD
Auranofin—Conjunctivitis—Mitoxantrone—multiple sclerosis	0.000763	0.00631	CcSEcCtD
Auranofin—Glossitis—Methotrexate—multiple sclerosis	0.000758	0.00627	CcSEcCtD
Auranofin—Haematuria—Mitoxantrone—multiple sclerosis	0.000748	0.00619	CcSEcCtD
Auranofin—Thrombocytopenia—Cladribine—multiple sclerosis	0.000745	0.00617	CcSEcCtD
Auranofin—Hepatic enzyme increased—Methotrexate—multiple sclerosis	0.000739	0.00611	CcSEcCtD
Auranofin—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.000732	0.00606	CcSEcCtD
Auranofin—Anorexia—Cladribine—multiple sclerosis	0.000726	0.006	CcSEcCtD
Auranofin—Anaemia—Azathioprine—multiple sclerosis	0.000701	0.0058	CcSEcCtD
Auranofin—Melaena—Methotrexate—multiple sclerosis	0.000683	0.00565	CcSEcCtD
Auranofin—Leukopenia—Azathioprine—multiple sclerosis	0.000679	0.00562	CcSEcCtD
Auranofin—Decreased appetite—Cladribine—multiple sclerosis	0.000662	0.00547	CcSEcCtD
Auranofin—Aplastic anaemia—Methotrexate—multiple sclerosis	0.000656	0.00543	CcSEcCtD
Auranofin—Constipation—Cladribine—multiple sclerosis	0.000651	0.00539	CcSEcCtD
Auranofin—Neuropathy peripheral—Prednisolone—multiple sclerosis	0.000631	0.00522	CcSEcCtD
Auranofin—Conjunctivitis—Prednisolone—multiple sclerosis	0.000626	0.00518	CcSEcCtD
Auranofin—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000622	0.00515	CcSEcCtD
Auranofin—Alopecia—Mitoxantrone—multiple sclerosis	0.000622	0.00515	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Prednisone—multiple sclerosis	0.000607	0.00502	CcSEcCtD
Auranofin—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000606	0.00501	CcSEcCtD
Auranofin—Urticaria—Cladribine—multiple sclerosis	0.000605	0.005	CcSEcCtD
Auranofin—Abdominal pain—Cladribine—multiple sclerosis	0.000602	0.00498	CcSEcCtD
Auranofin—Dysgeusia—Mitoxantrone—multiple sclerosis	0.0006	0.00497	CcSEcCtD
Auranofin—Neuropathy peripheral—Triamcinolone—multiple sclerosis	0.00058	0.0048	CcSEcCtD
Auranofin—Neuropathy peripheral—Methylprednisolone—multiple sclerosis	0.000579	0.00479	CcSEcCtD
Auranofin—Conjunctivitis—Triamcinolone—multiple sclerosis	0.000575	0.00476	CcSEcCtD
Auranofin—Anaemia—Mitoxantrone—multiple sclerosis	0.000567	0.00469	CcSEcCtD
Auranofin—Visual impairment—Prednisolone—multiple sclerosis	0.000557	0.00461	CcSEcCtD
Auranofin—Leukopenia—Mitoxantrone—multiple sclerosis	0.000549	0.00454	CcSEcCtD
Auranofin—Weight decreased—Dexamethasone—multiple sclerosis	0.000545	0.00451	CcSEcCtD
Auranofin—Weight decreased—Betamethasone—multiple sclerosis	0.000545	0.00451	CcSEcCtD
Auranofin—Pruritus—Cladribine—multiple sclerosis	0.000539	0.00446	CcSEcCtD
Auranofin—Dermatitis exfoliative—Methotrexate—multiple sclerosis	0.000538	0.00445	CcSEcCtD
Auranofin—Neuropathy peripheral—Betamethasone—multiple sclerosis	0.000526	0.00436	CcSEcCtD
Auranofin—Neuropathy peripheral—Dexamethasone—multiple sclerosis	0.000526	0.00436	CcSEcCtD
Auranofin—Conjunctivitis—Betamethasone—multiple sclerosis	0.000522	0.00432	CcSEcCtD
Auranofin—Conjunctivitis—Dexamethasone—multiple sclerosis	0.000522	0.00432	CcSEcCtD
Auranofin—Diarrhoea—Cladribine—multiple sclerosis	0.000521	0.00431	CcSEcCtD
Auranofin—Visual impairment—Methylprednisolone—multiple sclerosis	0.000511	0.00423	CcSEcCtD
Auranofin—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000506	0.00419	CcSEcCtD
Auranofin—Eye disorder—Methylprednisolone—multiple sclerosis	0.000495	0.0041	CcSEcCtD
Auranofin—Neutropenia—Prednisone—multiple sclerosis	0.000491	0.00406	CcSEcCtD
Auranofin—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.00049	0.00405	CcSEcCtD
Auranofin—Abdominal pain—Azathioprine—multiple sclerosis	0.000489	0.00405	CcSEcCtD
Auranofin—Vomiting—Cladribine—multiple sclerosis	0.000484	0.004	CcSEcCtD
Auranofin—Rash—Cladribine—multiple sclerosis	0.00048	0.00397	CcSEcCtD
Auranofin—Dermatitis—Cladribine—multiple sclerosis	0.00048	0.00397	CcSEcCtD
Auranofin—Anorexia—Mitoxantrone—multiple sclerosis	0.000477	0.00395	CcSEcCtD
Auranofin—Weight decreased—Prednisone—multiple sclerosis	0.000475	0.00393	CcSEcCtD
Auranofin—Visual impairment—Dexamethasone—multiple sclerosis	0.000465	0.00384	CcSEcCtD
Auranofin—Visual impairment—Betamethasone—multiple sclerosis	0.000465	0.00384	CcSEcCtD
Auranofin—Angioedema—Prednisolone—multiple sclerosis	0.00046	0.0038	CcSEcCtD
Auranofin—Neuropathy peripheral—Prednisone—multiple sclerosis	0.000458	0.00379	CcSEcCtD
Auranofin—Dysgeusia—Triamcinolone—multiple sclerosis	0.000453	0.00375	CcSEcCtD
Auranofin—Nausea—Cladribine—multiple sclerosis	0.000452	0.00374	CcSEcCtD
Auranofin—Eye disorder—Dexamethasone—multiple sclerosis	0.000451	0.00373	CcSEcCtD
Auranofin—Eye disorder—Betamethasone—multiple sclerosis	0.000451	0.00373	CcSEcCtD
Auranofin—Dyspepsia—Mitoxantrone—multiple sclerosis	0.00044	0.00364	CcSEcCtD
Auranofin—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000435	0.0036	CcSEcCtD
Auranofin—Eosinophilia—Methotrexate—multiple sclerosis	0.000434	0.00359	CcSEcCtD
Auranofin—Constipation—Mitoxantrone—multiple sclerosis	0.000428	0.00354	CcSEcCtD
Auranofin—Alopecia—Dexamethasone—multiple sclerosis	0.000426	0.00352	CcSEcCtD
Auranofin—Alopecia—Betamethasone—multiple sclerosis	0.000426	0.00352	CcSEcCtD
Auranofin—Diarrhoea—Azathioprine—multiple sclerosis	0.000423	0.0035	CcSEcCtD
Auranofin—Angioedema—Triamcinolone—multiple sclerosis	0.000423	0.0035	CcSEcCtD
Auranofin—Angioedema—Methylprednisolone—multiple sclerosis	0.000422	0.00349	CcSEcCtD
Auranofin—Pancytopenia—Methotrexate—multiple sclerosis	0.000416	0.00344	CcSEcCtD
Auranofin—Neutropenia—Methotrexate—multiple sclerosis	0.00041	0.00339	CcSEcCtD
Auranofin—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000409	0.00338	CcSEcCtD
Auranofin—Urticaria—Mitoxantrone—multiple sclerosis	0.000397	0.00329	CcSEcCtD
Auranofin—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000396	0.00327	CcSEcCtD
Auranofin—Vomiting—Azathioprine—multiple sclerosis	0.000394	0.00326	CcSEcCtD
Auranofin—Eye disorder—Prednisone—multiple sclerosis	0.000392	0.00325	CcSEcCtD
Auranofin—Rash—Azathioprine—multiple sclerosis	0.00039	0.00323	CcSEcCtD
Auranofin—Dermatitis—Azathioprine—multiple sclerosis	0.00039	0.00323	CcSEcCtD
Auranofin—Angioedema—Dexamethasone—multiple sclerosis	0.000383	0.00317	CcSEcCtD
Auranofin—Angioedema—Betamethasone—multiple sclerosis	0.000383	0.00317	CcSEcCtD
Auranofin—Stomatitis—Methotrexate—multiple sclerosis	0.000381	0.00315	CcSEcCtD
Auranofin—Conjunctivitis—Methotrexate—multiple sclerosis	0.00038	0.00314	CcSEcCtD
Auranofin—Haematuria—Methotrexate—multiple sclerosis	0.000373	0.00308	CcSEcCtD
Auranofin—Alopecia—Prednisone—multiple sclerosis	0.000371	0.00307	CcSEcCtD
Auranofin—Nausea—Azathioprine—multiple sclerosis	0.000368	0.00304	CcSEcCtD
Auranofin—Agranulocytosis—Methotrexate—multiple sclerosis	0.000365	0.00302	CcSEcCtD
Auranofin—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000342	0.00283	CcSEcCtD
Auranofin—Visual impairment—Methotrexate—multiple sclerosis	0.000338	0.0028	CcSEcCtD
Auranofin—Anaemia—Prednisone—multiple sclerosis	0.000338	0.00279	CcSEcCtD
Auranofin—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000335	0.00277	CcSEcCtD
Auranofin—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000335	0.00277	CcSEcCtD
Auranofin—Angioedema—Prednisone—multiple sclerosis	0.000334	0.00276	CcSEcCtD
Auranofin—Dyspepsia—Triamcinolone—multiple sclerosis	0.000332	0.00275	CcSEcCtD
Auranofin—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000332	0.00274	CcSEcCtD
Auranofin—Eye disorder—Methotrexate—multiple sclerosis	0.000328	0.00271	CcSEcCtD
Auranofin—Anorexia—Dexamethasone—multiple sclerosis	0.000327	0.0027	CcSEcCtD
Auranofin—Anorexia—Betamethasone—multiple sclerosis	0.000327	0.0027	CcSEcCtD
Auranofin—Urticaria—Prednisolone—multiple sclerosis	0.000326	0.0027	CcSEcCtD
Auranofin—Vomiting—Mitoxantrone—multiple sclerosis	0.000318	0.00263	CcSEcCtD
Auranofin—Rash—Mitoxantrone—multiple sclerosis	0.000315	0.00261	CcSEcCtD
Auranofin—Dermatitis—Mitoxantrone—multiple sclerosis	0.000315	0.00261	CcSEcCtD
Auranofin—Alopecia—Methotrexate—multiple sclerosis	0.00031	0.00257	CcSEcCtD
Auranofin—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000308	0.00255	CcSEcCtD
Auranofin—Dyspepsia—Betamethasone—multiple sclerosis	0.000302	0.00249	CcSEcCtD
Auranofin—Dyspepsia—Dexamethasone—multiple sclerosis	0.000302	0.00249	CcSEcCtD
Auranofin—Urticaria—Triamcinolone—multiple sclerosis	0.0003	0.00248	CcSEcCtD
Auranofin—Urticaria—Methylprednisolone—multiple sclerosis	0.000299	0.00248	CcSEcCtD
Auranofin—Dysgeusia—Methotrexate—multiple sclerosis	0.000299	0.00247	CcSEcCtD
Auranofin—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000298	0.00246	CcSEcCtD
Auranofin—Decreased appetite—Betamethasone—multiple sclerosis	0.000298	0.00246	CcSEcCtD
Auranofin—Decreased appetite—Dexamethasone—multiple sclerosis	0.000298	0.00246	CcSEcCtD
Auranofin—Nausea—Mitoxantrone—multiple sclerosis	0.000297	0.00246	CcSEcCtD
Auranofin—Anorexia—Prednisone—multiple sclerosis	0.000284	0.00235	CcSEcCtD
Auranofin—Anaemia—Methotrexate—multiple sclerosis	0.000282	0.00234	CcSEcCtD
Auranofin—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00028	0.00232	CcSEcCtD
Auranofin—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00028	0.00232	CcSEcCtD
Auranofin—Leukopenia—Methotrexate—multiple sclerosis	0.000273	0.00226	CcSEcCtD
Auranofin—Urticaria—Dexamethasone—multiple sclerosis	0.000272	0.00225	CcSEcCtD
Auranofin—Urticaria—Betamethasone—multiple sclerosis	0.000272	0.00225	CcSEcCtD
Auranofin—Abdominal pain—Dexamethasone—multiple sclerosis	0.000271	0.00224	CcSEcCtD
Auranofin—Abdominal pain—Betamethasone—multiple sclerosis	0.000271	0.00224	CcSEcCtD
Auranofin—Pruritus—Triamcinolone—multiple sclerosis	0.000267	0.00221	CcSEcCtD
Auranofin—Pruritus—Methylprednisolone—multiple sclerosis	0.000266	0.0022	CcSEcCtD
Auranofin—Dyspepsia—Prednisone—multiple sclerosis	0.000263	0.00217	CcSEcCtD
Auranofin—Decreased appetite—Prednisone—multiple sclerosis	0.000259	0.00215	CcSEcCtD
Auranofin—Rash—Prednisolone—multiple sclerosis	0.000259	0.00214	CcSEcCtD
Auranofin—Dermatitis—Prednisolone—multiple sclerosis	0.000259	0.00214	CcSEcCtD
Auranofin—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000258	0.00213	CcSEcCtD
Auranofin—Constipation—Prednisone—multiple sclerosis	0.000255	0.00211	CcSEcCtD
Auranofin—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000244	0.00202	CcSEcCtD
Auranofin—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000244	0.00202	CcSEcCtD
Auranofin—Nausea—Prednisolone—multiple sclerosis	0.000244	0.00202	CcSEcCtD
Auranofin—Pruritus—Dexamethasone—multiple sclerosis	0.000242	0.002	CcSEcCtD
Auranofin—Pruritus—Betamethasone—multiple sclerosis	0.000242	0.002	CcSEcCtD
Auranofin—Vomiting—Triamcinolone—multiple sclerosis	0.00024	0.00199	CcSEcCtD
Auranofin—Vomiting—Methylprednisolone—multiple sclerosis	0.000239	0.00198	CcSEcCtD
Auranofin—Rash—Triamcinolone—multiple sclerosis	0.000238	0.00197	CcSEcCtD
Auranofin—Dermatitis—Triamcinolone—multiple sclerosis	0.000238	0.00197	CcSEcCtD
Auranofin—Anorexia—Methotrexate—multiple sclerosis	0.000238	0.00197	CcSEcCtD
Auranofin—Rash—Methylprednisolone—multiple sclerosis	0.000237	0.00196	CcSEcCtD
Auranofin—Dermatitis—Methylprednisolone—multiple sclerosis	0.000237	0.00196	CcSEcCtD
Auranofin—Urticaria—Prednisone—multiple sclerosis	0.000237	0.00196	CcSEcCtD
Auranofin—Abdominal pain—Prednisone—multiple sclerosis	0.000236	0.00195	CcSEcCtD
Auranofin—Diarrhoea—Betamethasone—multiple sclerosis	0.000234	0.00194	CcSEcCtD
Auranofin—Diarrhoea—Dexamethasone—multiple sclerosis	0.000234	0.00194	CcSEcCtD
Auranofin—Nausea—Triamcinolone—multiple sclerosis	0.000224	0.00185	CcSEcCtD
Auranofin—Nausea—Methylprednisolone—multiple sclerosis	0.000224	0.00185	CcSEcCtD
Auranofin—Dyspepsia—Methotrexate—multiple sclerosis	0.000219	0.00182	CcSEcCtD
Auranofin—Vomiting—Dexamethasone—multiple sclerosis	0.000218	0.0018	CcSEcCtD
Auranofin—Vomiting—Betamethasone—multiple sclerosis	0.000218	0.0018	CcSEcCtD
Auranofin—Decreased appetite—Methotrexate—multiple sclerosis	0.000217	0.00179	CcSEcCtD
Auranofin—Rash—Betamethasone—multiple sclerosis	0.000216	0.00179	CcSEcCtD
Auranofin—Rash—Dexamethasone—multiple sclerosis	0.000216	0.00179	CcSEcCtD
Auranofin—Dermatitis—Betamethasone—multiple sclerosis	0.000216	0.00179	CcSEcCtD
Auranofin—Dermatitis—Dexamethasone—multiple sclerosis	0.000216	0.00179	CcSEcCtD
Auranofin—Pruritus—Prednisone—multiple sclerosis	0.000211	0.00175	CcSEcCtD
Auranofin—IKBKB—Adaptive Immune System—CBLB—multiple sclerosis	0.000209	0.00101	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—TYK2—multiple sclerosis	0.000206	0.000993	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—IFNG—multiple sclerosis	0.000205	0.000988	CbGpPWpGaD
Auranofin—Diarrhoea—Prednisone—multiple sclerosis	0.000204	0.00169	CcSEcCtD
Auranofin—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000204	0.00169	CcSEcCtD
Auranofin—Nausea—Dexamethasone—multiple sclerosis	0.000203	0.00168	CcSEcCtD
Auranofin—Nausea—Betamethasone—multiple sclerosis	0.000203	0.00168	CcSEcCtD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—IL1B—multiple sclerosis	0.000198	0.000957	CbGpPWpGaD
Auranofin—Urticaria—Methotrexate—multiple sclerosis	0.000198	0.00164	CcSEcCtD
Auranofin—Abdominal pain—Methotrexate—multiple sclerosis	0.000197	0.00163	CcSEcCtD
Auranofin—ALB—Folate Metabolism—CCL2—multiple sclerosis	0.000196	0.000945	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—STAT3—multiple sclerosis	0.000194	0.000938	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—MAPK1—multiple sclerosis	0.000193	0.000933	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—MAPK1—multiple sclerosis	0.000193	0.000933	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—VCAM1—multiple sclerosis	0.000191	0.000924	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—HLA-DQA1—multiple sclerosis	0.000191	0.000921	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—CD80—multiple sclerosis	0.00019	0.000915	CbGpPWpGaD
Auranofin—Vomiting—Prednisone—multiple sclerosis	0.00019	0.00157	CcSEcCtD
Auranofin—IKBKB—Signaling by Interleukins—IL1B—multiple sclerosis	0.00019	0.000915	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—IL2—multiple sclerosis	0.000189	0.000911	CbGpPWpGaD
Auranofin—Rash—Prednisone—multiple sclerosis	0.000188	0.00156	CcSEcCtD
Auranofin—Dermatitis—Prednisone—multiple sclerosis	0.000188	0.00155	CcSEcCtD
Auranofin—IKBKB—Immune System—P2RX7—multiple sclerosis	0.000186	0.000898	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—TYK2—multiple sclerosis	0.000183	0.000885	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—IL1B—multiple sclerosis	0.000183	0.000881	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—CD80—multiple sclerosis	0.000181	0.000874	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—MYC—multiple sclerosis	0.000181	0.000871	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—multiple sclerosis	0.00018	0.000869	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HLA-DRA—multiple sclerosis	0.00018	0.000868	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—HLA-DQB1—multiple sclerosis	0.000179	0.000862	CbGpPWpGaD
Auranofin—Nausea—Prednisone—multiple sclerosis	0.000177	0.00147	CcSEcCtD
Auranofin—IKBKB—Innate Immune System—NOD1—multiple sclerosis	0.000177	0.000853	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—MAPK1—multiple sclerosis	0.000177	0.000852	CbGpPWpGaD
Auranofin—Pruritus—Methotrexate—multiple sclerosis	0.000176	0.00146	CcSEcCtD
Auranofin—IKBKB—MyD88 cascade initiated on plasma membrane—MAPK1—multiple sclerosis	0.000175	0.000844	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—ICAM1—multiple sclerosis	0.000174	0.000839	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—MAPK1—multiple sclerosis	0.000173	0.000836	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD226—multiple sclerosis	0.000173	0.000835	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MALT1—multiple sclerosis	0.000171	0.000824	CbGpPWpGaD
Auranofin—Diarrhoea—Methotrexate—multiple sclerosis	0.000171	0.00141	CcSEcCtD
Auranofin—IKBKB—TCR Signaling Pathway—TGFB1—multiple sclerosis	0.00017	0.000822	CbGpPWpGaD
Auranofin—IKBKB—MyD88 dependent cascade initiated on endosome—MAPK1—multiple sclerosis	0.00017	0.000821	CbGpPWpGaD
Auranofin—ALB—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000169	0.000817	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—CD86—multiple sclerosis	0.000169	0.000816	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—multiple sclerosis	0.000168	0.000811	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—TNF—multiple sclerosis	0.000168	0.000811	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HLA-DRB4—multiple sclerosis	0.000168	0.000809	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—CD80—multiple sclerosis	0.000168	0.000809	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—MAPK1—multiple sclerosis	0.000167	0.000806	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—IFNG—multiple sclerosis	0.000167	0.000804	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—MAPK1—multiple sclerosis	0.000164	0.000792	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—MAPK1—multiple sclerosis	0.000164	0.000792	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—MALT1—multiple sclerosis	0.000164	0.000791	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000162	0.000784	CbGpPWpGaD
Auranofin—IKBKB—MyD88:Mal cascade initiated on plasma membrane—MAPK1—multiple sclerosis	0.000161	0.000779	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—MYC—multiple sclerosis	0.000161	0.000776	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IFIH1—multiple sclerosis	0.00016	0.000774	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—HLA-B—multiple sclerosis	0.00016	0.000774	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—STAT3—multiple sclerosis	0.000159	0.000767	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000159	0.000766	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000159	0.000766	CbGpPWpGaD
Auranofin—Vomiting—Methotrexate—multiple sclerosis	0.000159	0.00131	CcSEcCtD
Auranofin—IKBKB—Immune System—CIITA—multiple sclerosis	0.000158	0.000764	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—MAPK1—multiple sclerosis	0.000157	0.00076	CbGpPWpGaD
Auranofin—Rash—Methotrexate—multiple sclerosis	0.000157	0.0013	CcSEcCtD
Auranofin—Dermatitis—Methotrexate—multiple sclerosis	0.000157	0.0013	CcSEcCtD
Auranofin—IKBKB—TNF alpha Signaling Pathway—TNF—multiple sclerosis	0.000156	0.000755	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	0.000156	0.000751	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—IL1B—multiple sclerosis	0.000155	0.000747	CbGpPWpGaD
Auranofin—IKBKB—MyD88-independent cascade—MAPK1—multiple sclerosis	0.000155	0.000747	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HLA-G—multiple sclerosis	0.000154	0.000744	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—TYK2—multiple sclerosis	0.000153	0.000738	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—MAPK1—multiple sclerosis	0.000151	0.00073	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL2RA—multiple sclerosis	0.00015	0.000725	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—TNFAIP3—multiple sclerosis	0.00015	0.000725	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—HLA-A—multiple sclerosis	0.000149	0.000717	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—multiple sclerosis	0.000149	0.000717	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—IL1B—multiple sclerosis	0.000149	0.000717	CbGpPWpGaD
Auranofin—Nausea—Methotrexate—multiple sclerosis	0.000148	0.00123	CcSEcCtD
Auranofin—ALB—Folate Metabolism—IL2—multiple sclerosis	0.000148	0.000714	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL7—multiple sclerosis	0.000147	0.00071	CbGpPWpGaD
Auranofin—IKBKB—Immune System—C4A—multiple sclerosis	0.000147	0.00071	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—MAPK1—multiple sclerosis	0.000144	0.000697	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—TNF—multiple sclerosis	0.000144	0.000695	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PLEK—multiple sclerosis	0.000142	0.000686	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PDCD1—multiple sclerosis	0.000141	0.000681	CbGpPWpGaD
Auranofin—IKBKB—Activated TLR4 signalling—MAPK1—multiple sclerosis	0.000139	0.000672	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—LINGO1—multiple sclerosis	0.000139	0.00067	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL7R—multiple sclerosis	0.000138	0.000668	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—HLA-DRB1—multiple sclerosis	0.000136	0.000655	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CD28—multiple sclerosis	0.000135	0.000652	CbGpPWpGaD
Auranofin—IKBKB—MyD88 cascade initiated on plasma membrane—IL6—multiple sclerosis	0.000134	0.000649	CbGpPWpGaD
Auranofin—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—multiple sclerosis	0.000133	0.000643	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—IL1B—multiple sclerosis	0.000133	0.000642	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CCR2—multiple sclerosis	0.000133	0.00064	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	0.000133	0.000639	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	0.000132	0.000638	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—MAPK1—multiple sclerosis	0.000131	0.000632	CbGpPWpGaD
Auranofin—IKBKB—MyD88 dependent cascade initiated on endosome—IL6—multiple sclerosis	0.000131	0.000631	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—ICAM1—multiple sclerosis	0.00013	0.000629	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD28—multiple sclerosis	0.00013	0.000626	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—IL6—multiple sclerosis	0.000128	0.00062	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PTPRC—multiple sclerosis	0.000127	0.000615	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CBLB—multiple sclerosis	0.000127	0.000613	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—STAT3—multiple sclerosis	0.000126	0.000609	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—IL6—multiple sclerosis	0.000126	0.000609	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—IL6—multiple sclerosis	0.000126	0.000609	CbGpPWpGaD
Auranofin—IKBKB—MyD88:Mal cascade initiated on plasma membrane—IL6—multiple sclerosis	0.000124	0.000599	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—CD80—multiple sclerosis	0.000123	0.000595	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HLA-DPB1—multiple sclerosis	0.000123	0.000594	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000123	0.000594	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IFNB1—multiple sclerosis	0.000123	0.000591	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TAGAP—multiple sclerosis	0.00012	0.000581	CbGpPWpGaD
Auranofin—IKBKB—MyD88-independent cascade—IL6—multiple sclerosis	0.000119	0.000574	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—ITGA4—multiple sclerosis	0.000119	0.000572	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD40—multiple sclerosis	0.000119	0.000572	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—MAPK1—multiple sclerosis	0.000118	0.00057	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	0.000118	0.000569	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CTLA4—multiple sclerosis	0.000117	0.000563	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—MAPK1—multiple sclerosis	0.000117	0.000563	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—IL6—multiple sclerosis	0.000116	0.000561	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—MAPK1—multiple sclerosis	0.000115	0.000554	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MX1—multiple sclerosis	0.000113	0.000544	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—multiple sclerosis	0.000112	0.000542	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—IL6—multiple sclerosis	0.000111	0.000536	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HLA-DRA—multiple sclerosis	0.000109	0.000527	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TNF—multiple sclerosis	0.000108	0.00052	CbGpPWpGaD
Auranofin—IKBKB—Activated TLR4 signalling—IL6—multiple sclerosis	0.000107	0.000517	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	0.000107	0.000516	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—TYK2—multiple sclerosis	0.000106	0.000511	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—MAPK1—multiple sclerosis	0.000105	0.000509	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—S1PR1—multiple sclerosis	0.000105	0.000508	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—TYK2—multiple sclerosis	0.000104	0.000502	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—MYC—multiple sclerosis	0.000104	0.0005	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TGFB1—multiple sclerosis	0.000103	0.000499	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—VCAM1—multiple sclerosis	0.000103	0.000497	CbGpPWpGaD
Auranofin—IKBKB—Immune System—NOD1—multiple sclerosis	0.000103	0.000497	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HLA-DQA1—multiple sclerosis	0.000103	0.000496	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GPC5—multiple sclerosis	0.000102	0.000494	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—MAPK1—multiple sclerosis	0.000101	0.000489	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—multiple sclerosis	0.000101	0.000486	CbGpPWpGaD
Auranofin—ALB—Metabolism—SRM—multiple sclerosis	0.0001	0.000484	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SELE—multiple sclerosis	0.0001	0.000483	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MALT1—multiple sclerosis	9.94e-05	0.00048	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IFNG—multiple sclerosis	9.92e-05	0.000479	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—TGFB1—multiple sclerosis	9.9e-05	0.000478	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IRF5—multiple sclerosis	9.78e-05	0.000472	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	9.73e-05	0.00047	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—MAPK1—multiple sclerosis	9.73e-05	0.000469	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TNF—multiple sclerosis	9.66e-05	0.000466	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CD86—multiple sclerosis	9.65e-05	0.000465	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HLA-DQB1—multiple sclerosis	9.62e-05	0.000464	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	9.6e-05	0.000463	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	9.43e-05	0.000455	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IFIH1—multiple sclerosis	9.35e-05	0.000451	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IRF8—multiple sclerosis	9.35e-05	0.000451	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HLA-G—multiple sclerosis	9.35e-05	0.000451	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD86—multiple sclerosis	9.26e-05	0.000447	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD40LG—multiple sclerosis	9.08e-05	0.000438	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—multiple sclerosis	9.07e-05	0.000438	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—HLA-B—multiple sclerosis	9e-05	0.000434	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD8A—multiple sclerosis	8.98e-05	0.000433	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—IL6—multiple sclerosis	8.97e-05	0.000433	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RGS1—multiple sclerosis	8.95e-05	0.000432	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL1B—multiple sclerosis	8.85e-05	0.000427	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL2—multiple sclerosis	8.81e-05	0.000425	CbGpPWpGaD
Auranofin—IKBKB—Immune System—TNFAIP3—multiple sclerosis	8.75e-05	0.000422	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—IL6—multiple sclerosis	8.7e-05	0.00042	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HLA-B—multiple sclerosis	8.64e-05	0.000417	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.6e-05	0.000415	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	8.56e-05	0.000413	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GPR65—multiple sclerosis	8.48e-05	0.000409	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HLA-A—multiple sclerosis	8e-05	0.000386	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD28—multiple sclerosis	7.87e-05	0.00038	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCL13—multiple sclerosis	7.76e-05	0.000374	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCR1—multiple sclerosis	7.76e-05	0.000374	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PTPRC—multiple sclerosis	7.73e-05	0.000373	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CCR2—multiple sclerosis	7.73e-05	0.000373	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—TLR4—multiple sclerosis	7.62e-05	0.000368	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—multiple sclerosis	7.48e-05	0.000361	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HLA-DPB1—multiple sclerosis	7.47e-05	0.000361	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—STAT3—multiple sclerosis	7.42e-05	0.000358	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HLA-DRB1—multiple sclerosis	7.31e-05	0.000353	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—STAT3—multiple sclerosis	7.29e-05	0.000352	CbGpPWpGaD
Auranofin—ALB—Hemostasis—ITGA4—multiple sclerosis	7.24e-05	0.00035	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IFNB1—multiple sclerosis	7.19e-05	0.000347	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD40—multiple sclerosis	7.19e-05	0.000347	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ITGA4—multiple sclerosis	7.19e-05	0.000347	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IFNB1—multiple sclerosis	7.14e-05	0.000344	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CTLA4—multiple sclerosis	7.08e-05	0.000342	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP24A1—multiple sclerosis	7.07e-05	0.000341	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP27B1—multiple sclerosis	7.07e-05	0.000341	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CD80—multiple sclerosis	7.04e-05	0.000339	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—ICAM1—multiple sclerosis	7.02e-05	0.000339	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.91e-05	0.000334	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	6.91e-05	0.000333	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD80—multiple sclerosis	6.76e-05	0.000326	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—MAPK1—multiple sclerosis	6.74e-05	0.000325	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—MAPK1—multiple sclerosis	6.63e-05	0.00032	CbGpPWpGaD
Auranofin—ALB—Metabolism—GPC5—multiple sclerosis	6.47e-05	0.000312	CbGpPWpGaD
Auranofin—IKBKB—Immune System—VCAM1—multiple sclerosis	6.25e-05	0.000302	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HLA-DQA1—multiple sclerosis	6.24e-05	0.000301	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—TYK2—multiple sclerosis	5.94e-05	0.000287	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HLA-DQB1—multiple sclerosis	5.83e-05	0.000281	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	5.63e-05	0.000272	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD86—multiple sclerosis	5.62e-05	0.000271	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCL3—multiple sclerosis	5.53e-05	0.000267	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD40LG—multiple sclerosis	5.51e-05	0.000266	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD8A—multiple sclerosis	5.45e-05	0.000263	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CD4—multiple sclerosis	5.37e-05	0.000259	CbGpPWpGaD
Auranofin—ALB—Metabolism—RRM1—multiple sclerosis	5.36e-05	0.000259	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTGER4—multiple sclerosis	5.32e-05	0.000257	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HLA-B—multiple sclerosis	5.24e-05	0.000253	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PGR—multiple sclerosis	5.24e-05	0.000253	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL6—multiple sclerosis	5.18e-05	0.00025	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD4—multiple sclerosis	5.16e-05	0.000249	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCR3—multiple sclerosis	5.14e-05	0.000248	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—IL6—multiple sclerosis	5.09e-05	0.000246	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CD28—multiple sclerosis	5.09e-05	0.000246	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCR2—multiple sclerosis	5e-05	0.000241	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IL2RA—multiple sclerosis	4.95e-05	0.000239	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL2RA—multiple sclerosis	4.91e-05	0.000237	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HLA-A—multiple sclerosis	4.86e-05	0.000234	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CNR1—multiple sclerosis	4.61e-05	0.000223	CbGpPWpGaD
Auranofin—IKBKB—Immune System—TLR4—multiple sclerosis	4.44e-05	0.000214	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HLA-DRB1—multiple sclerosis	4.44e-05	0.000214	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	4.39e-05	0.000212	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	4.31e-05	0.000208	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ICAM1—multiple sclerosis	4.26e-05	0.000205	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.16e-05	0.000201	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCL10—multiple sclerosis	4.15e-05	0.0002	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD80—multiple sclerosis	4.1e-05	0.000198	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MAPK1—multiple sclerosis	3.78e-05	0.000182	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CD86—multiple sclerosis	3.63e-05	0.000175	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCL5—multiple sclerosis	3.58e-05	0.000173	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.57e-05	0.000172	CbGpPWpGaD
Auranofin—IKBKB—Immune System—TYK2—multiple sclerosis	3.46e-05	0.000167	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SPP1—multiple sclerosis	3.31e-05	0.00016	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IFNG—multiple sclerosis	3.24e-05	0.000156	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCR5—multiple sclerosis	3.22e-05	0.000155	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL2RA—multiple sclerosis	3.17e-05	0.000153	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD4—multiple sclerosis	3.13e-05	0.000151	CbGpPWpGaD
Auranofin—ALB—Metabolism—BCHE—multiple sclerosis	3.08e-05	0.000149	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APOE—multiple sclerosis	2.93e-05	0.000141	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IL6—multiple sclerosis	2.91e-05	0.00014	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IL2—multiple sclerosis	2.9e-05	0.00014	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL1B—multiple sclerosis	2.89e-05	0.000139	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL2—multiple sclerosis	2.88e-05	0.000139	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CD80—multiple sclerosis	2.65e-05	0.000128	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—POMC—multiple sclerosis	2.52e-05	0.000121	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCL2—multiple sclerosis	2.46e-05	0.000119	CbGpPWpGaD
Auranofin—IKBKB—Immune System—STAT3—multiple sclerosis	2.42e-05	0.000117	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TGFB1—multiple sclerosis	2.26e-05	0.000109	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TYK2—multiple sclerosis	2.24e-05	0.000108	CbGpPWpGaD
Auranofin—ALB—Hemostasis—MAPK1—multiple sclerosis	2.22e-05	0.000107	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MAPK1—multiple sclerosis	2.2e-05	0.000106	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL2—multiple sclerosis	1.86e-05	8.98e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—APOE—multiple sclerosis	1.85e-05	8.94e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MMP9—multiple sclerosis	1.76e-05	8.5e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL6—multiple sclerosis	1.69e-05	8.16e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—POMC—multiple sclerosis	1.59e-05	7.68e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—STAT3—multiple sclerosis	1.57e-05	7.56e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MYC—multiple sclerosis	1.46e-05	7.02e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TGFB1—multiple sclerosis	1.45e-05	7e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MAPK1—multiple sclerosis	1.42e-05	6.87e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL6—multiple sclerosis	1.09e-05	5.28e-05	CbGpPWpGaD
